Effects of physiological infusion of epinephrine in normal humans: Relationship between the metabolic response and β-adrenergic binding

V. R. Soman, Harry Shamoon, R. S. Sherwin

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In normal humans, infusion of epinephrine for 4 hr increased plasma epinephrine to 411 ± 38 pg/ml but had no significant effect on plasma insulin or glucagon levels. Epinephrine produced a prompt 45% rise in glucose output (P < 0.01) and a 120% rise in FFA (P < 0.001), both of which declined to basal levels by 60-90 min. Glucose clearance decreased by 25% (P < 0.005) and remained suppressed for 4 hr. The binding of [125I]hydroxybenzylpindolol to lymphocytes was unchanged after epinephrine infusion. The authors conlude that in normal humans physiological increments in epinephrine have a persistent effect in decreasing glucose clearance but only transiently increase hepatic glucose output and FFA levels; and this refractoriness of liver and adipose tissue to epinephrine occurs withoug a concomitant decrease in β-adrenergic binding to lymphocytes.

Original languageEnglish (US)
Pages (from-to)294-297
Number of pages4
JournalJournal of Clinical Endocrinology and Metabolism
Volume50
Issue number2
StatePublished - 1980
Externally publishedYes

Fingerprint

Adrenergic Agents
Epinephrine
Glucose
Lymphocytes
Plasmas
Liver
Glucagon
Adipose Tissue
Insulin
Tissue

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

@article{28574db5e2ea4e5096da01a4b5e3913a,
title = "Effects of physiological infusion of epinephrine in normal humans: Relationship between the metabolic response and β-adrenergic binding",
abstract = "In normal humans, infusion of epinephrine for 4 hr increased plasma epinephrine to 411 ± 38 pg/ml but had no significant effect on plasma insulin or glucagon levels. Epinephrine produced a prompt 45{\%} rise in glucose output (P < 0.01) and a 120{\%} rise in FFA (P < 0.001), both of which declined to basal levels by 60-90 min. Glucose clearance decreased by 25{\%} (P < 0.005) and remained suppressed for 4 hr. The binding of [125I]hydroxybenzylpindolol to lymphocytes was unchanged after epinephrine infusion. The authors conlude that in normal humans physiological increments in epinephrine have a persistent effect in decreasing glucose clearance but only transiently increase hepatic glucose output and FFA levels; and this refractoriness of liver and adipose tissue to epinephrine occurs withoug a concomitant decrease in β-adrenergic binding to lymphocytes.",
author = "Soman, {V. R.} and Harry Shamoon and Sherwin, {R. S.}",
year = "1980",
language = "English (US)",
volume = "50",
pages = "294--297",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Effects of physiological infusion of epinephrine in normal humans

T2 - Relationship between the metabolic response and β-adrenergic binding

AU - Soman, V. R.

AU - Shamoon, Harry

AU - Sherwin, R. S.

PY - 1980

Y1 - 1980

N2 - In normal humans, infusion of epinephrine for 4 hr increased plasma epinephrine to 411 ± 38 pg/ml but had no significant effect on plasma insulin or glucagon levels. Epinephrine produced a prompt 45% rise in glucose output (P < 0.01) and a 120% rise in FFA (P < 0.001), both of which declined to basal levels by 60-90 min. Glucose clearance decreased by 25% (P < 0.005) and remained suppressed for 4 hr. The binding of [125I]hydroxybenzylpindolol to lymphocytes was unchanged after epinephrine infusion. The authors conlude that in normal humans physiological increments in epinephrine have a persistent effect in decreasing glucose clearance but only transiently increase hepatic glucose output and FFA levels; and this refractoriness of liver and adipose tissue to epinephrine occurs withoug a concomitant decrease in β-adrenergic binding to lymphocytes.

AB - In normal humans, infusion of epinephrine for 4 hr increased plasma epinephrine to 411 ± 38 pg/ml but had no significant effect on plasma insulin or glucagon levels. Epinephrine produced a prompt 45% rise in glucose output (P < 0.01) and a 120% rise in FFA (P < 0.001), both of which declined to basal levels by 60-90 min. Glucose clearance decreased by 25% (P < 0.005) and remained suppressed for 4 hr. The binding of [125I]hydroxybenzylpindolol to lymphocytes was unchanged after epinephrine infusion. The authors conlude that in normal humans physiological increments in epinephrine have a persistent effect in decreasing glucose clearance but only transiently increase hepatic glucose output and FFA levels; and this refractoriness of liver and adipose tissue to epinephrine occurs withoug a concomitant decrease in β-adrenergic binding to lymphocytes.

UR - http://www.scopus.com/inward/record.url?scp=0018831247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018831247&partnerID=8YFLogxK

M3 - Article

C2 - 6243667

AN - SCOPUS:0018831247

VL - 50

SP - 294

EP - 297

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 2

ER -